Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:00 PM
Ignite Modification Date:
2025-12-24 @ 12:00 PM
NCT ID:
NCT03004261
Eligibility Criteria:
Inclusion Criteria:
* Any allogeneic stem cell transplant recipient ≥ 14 years of age and ≤ 60 years of age
* Bilirubin/ SGOT/SGPT \< 5 × upper normal limits.
* Creatinine \< 2 × upper normal limits.
* Ejection fraction ≥ 50%, no severe arrhythmia.
* Estimated life expectancy ≥ 6 months.
* Patients' CMV-DNA ≥ 1000cp/ml in treatment group and being negative in prophylactic group.
Exclusion Criteria:
* Patients receiving prednisone ≥ 1mg/kg/d for the treatment of acute GVHD or mild, severe chronic GVHD.
* Recipient \< 14years of age
* Donor is sero-positive in HBV/HCV/HIV or RPR.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
14 Years
Maximum Age:
60 Years
Study:
NCT03004261
Study Brief:
Protocol Section:
NCT03004261